Drug Trial Radar · NCT06937931
A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
Last checked: Nov 19, 2026Latest source record: Sep 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
132
Planned (sponsor's estimate)
Start
Jun 30, 2025
Primary completion
Mar 26, 2027
Study completion Nov 5, 2027
Sponsor
- Lead sponsor
- IpsenIndustry
- Sponsor type
- Industry
- First posted
- Apr 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of the study drug, Corabotase (also known as IPN10200), and to assess how well it works when compared with placebo in treating Cervical Dystonia (CD) in adults. CD can cause a series of abnormalities and symptoms in the head and neck that can lead to neck pain and stiffness, and headaches. CD is believed to involve deep parts within the brain that control movement, but genetic factors, environmental factors, and abnormalities in the brain may also play a role. The usual treatment for CD includes injecting BoNT into the affected muscles, but the treatment only lasts about 3 months. Corabotase is designed to last for a longer period. The study will consist of two periods: 1. A Screening Period of up to 4 weeks (28 days) to assess whether a participant can take part in the study and requires at least one visit. 2. A Treatment Period of 36 weeks. On Day 1 of the treatment period, participants will receive either Corabotase Dose A or Dose B (additional participants may receive Corabotase Dose C) of the study drug, or placebo distributed into different muscles in the head, neck and shoulders. Participants may continue some other medications, but details need to be recorded. There will be 10 visits to the clinic in person and one remote visits (phone call) (12 visits to the clinic for participants who receive Dose C). Participants will undergo blood samplings, urine collections, physical/neurological examinations, and clinical evaluations. Participants will also need to complete questionnaires throughout the study. The total study duration for a participant will be up to 40 weeks (approximately 9 months).
Conditions
- Cervical Dystonia
Interventions
CorabotaseBiological
Study intervention will be administered in a single treatment cycle after randomisation (Day 1). The administration cycle consists of intramuscular injection.
PlaceboOther
Excipients without active substance will be administered in a single treatment cycle after randomisation (Day 1). The administration cycle consists of intramuscular injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) total scoreTime frame: At Week 4
Locations
45 sites in 8 countries. Site status is shown where the registry gives one.
University of Arizona Health Sciences - Neurology
Tucson, Arizona · Active not recruiting
Parkinson's & Mvmt Disorders Inst
Fountain Valley, California · Recruiting
Loma Linda University School of Medicine - Neurology
Loma Linda, California · Withdrawn
Parkinson's Ds & Mvt Disorders Cntr
Boca Raton, Florida · Recruiting
USF Health Byrd Alzheimer's Institute
Tampa, Florida · Not yet recruiting
Emory Brain Health Center
Atlanta, Georgia · Recruiting
Rush Medical Center
Chicago, Illinois · Recruiting
Quest Research Institute
Farmington Hills, Michigan · Recruiting
Ichan Sch of Medicine @ Mt. Sinai
New York, New York · Recruiting
Kingfisher Cooperative
Spokane, Washington · Recruiting
Fakultni nemocnice u sv. Anny v Brne - I. Neurologicka klinika
Brno, Czechia · Recruiting
MINKSneuro s.r.o.
Brno, Czechia · Active not recruiting
NEUROHK s.r.o.
Choceň, Czechia · Recruiting
Fakultni nemocnice Olomouc - Neurologicka klinika
Olomouc, Czechia · Not yet recruiting
Vseobecna fakultni nemocnice v Praze - Neurologicka klinika
Prague, Czechia · Withdrawn
CHU Grenoble Alpes - Site Nord - Neurology
Grenoble, France · Recruiting
Timone University Hospital
Marseille, France · Active not recruiting
CHU Nimes - Hôpital Caremeau
Nîmes, France · Recruiting
Hopitaux Universitaire de Strasbourg - Hopital de Hautepierre - Neurologie
Strasbourg, France · Active not recruiting
Centre Hospitalier Universitaire (CHU) Purpan - Institut Des Sciences du Cerveau De Toulouse (Institute for Brain Sciences)
Toulouse, France · Recruiting
Curiositas ad sanum Studien- und Beratungs GmbH Haag i.OB - Neurologie
Haag in Oberbayern, Germany · Recruiting
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany · Not yet recruiting
GFO Kliniken Troisdorf
Troisdorf, Germany · Recruiting
University Hospital Tuebingen - Neurologie
Tübingen, Germany · Active not recruiting
Ospedale Bellaria, IRCCS Istituto delle Scienze Neurologiche, AUSL Bologna
Bologna, Italy · Recruiting
Istituto Auxologico Italiano - Auxologico San Luca
Milan, Italy · Recruiting
Istituto Neurologico C. Besta
Milan, Italy · Active not recruiting
IRCCS C.Mondino, Istituto Neurologico Nazionale, Fondazione
Pavia, Italy · Recruiting
Azienda USL-IRCCS di Reggio Emilia - Presidio ospedaliero provinciale sede di Reggio Emilia
Reggio Emilia, Italy · Not yet recruiting
Specjalistyczna Praktyka Lekarska Dr Stanislaw Ochudlo
Katowice, Poland · Withdrawn
Futuremeds Krakow
Krakow, Poland · Recruiting
SP ZOZ Szpital Uniwersytecki w Krakowie
Krakow, Poland · Recruiting
Instytut Zdrowia Dr Boczarska-Jedynak Sp. z o.o. S.K.
Oświęcim, Poland · Recruiting
Eskulap Pabianice Sp z o.o.
Pabianice, Poland · Recruiting
ETG Neuroscience Sp. z o.o.
Warsaw, Poland · Recruiting
Wojewodzki Szpital Specjalistyczny im. J. Gromkowskiego
Wroclaw, Poland · Withdrawn
Hospital de la Santa Creu i Sant Pau - Neurología
Barcelona, Spain · Active not recruiting
H.U. Puerta del Mar - Neurocirugía
Cadiz, Spain · Recruiting
Hospital Universitario De La Princesa
Madrid, Spain · Recruiting
Hospital Universitario Ramon y Cajal - Neurologia
Madrid, Spain · Withdrawn
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.